Mixed Reality Gains a Foothold in the Lab

Marks called out an ‘assault’ on truth and science in his resignation letter, which has sent the bio/pharmaceutical industry reeling.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Three of the five are biosimilars, and seven additional medicines received recommendations for indication extensions.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs.

In response to a presidential Executive Order, the Department of Health and Human Services is planning to reduce its workforce, including cutting FDA staff by 3500 full-time employees, and reorganize some key departments.